Leica Biosystems has added Tempus’ Paige PanCancer Detect and Paige Prostate AI tools to the Aperio AI Store, expanding integrated digital pathology solutions for oncology research within the Aperio HALO AP platform.
OGT has expanded its SureSeq Universal NGS Unique Dual Index portfolio, enabling up to 384 uniquely indexed samples per run on Illumina platforms, quadrupling previous capacity and supporting higher-throughput workflows, according to the company.
Urinalysis comparison guide featuring testing capabilities, technology, throughput, connectivity, sample capacity, and key specifications from leading systems.
Hamamatsu Photonics received FDA 510(k) clearance for its NanoZoomer S20MD and S540MD slide scanner systems, expanding digital pathology options for clinical labs to include compact benchtop and high-throughput workflows.
AI models analyzing routine H&E slides can identify genomic alterations and immune patterns in NSCLC, supporting biomarker discovery and patient stratification, according to studies to be presented by Lunit at WCLC 2026.
Quest Diagnostics will integrate a 50-biomarker lab test panel into the Apple Health app, allowing US users to order preventive testing and access clinical results on iPhone and iPad.
Hematogenix’s next-generation flow cytometry assay was used as the pivotal efficacy measure supporting FDA accelerated approval of ZENBEXUS, the first CELMoD therapy for multiple myeloma.
MolDX has proposed a draft Local Coverage Determination to establish Medicare coverage criteria for optical genome mapping in hematologic neoplasms, with public comment open through Oct. 11, 2026, according to Bionano Laboratories.
Health Canada has approved Fujirebio’s Lumipulse G NfL Blood and pTau 217 Plasma assays, expanding access to blood-based neurology biomarkers for clinical use on the Lumipulse G immunoassay platform.
Pillar Biosciences and Hamilton Company have launched an automated NGS library prep method for the oncoReveal Nexus 21 Gene Panel, validated for use on Hamilton’s Microlab STAR and STARlet liquid handling systems.
Astorg has completed its acquisition of Thermo Fisher’s global microbiology business, establishing an independent diagnostics company. Dirk Bontridder has been named CEO.
Helix has introduced Whole Exome+ Sequencing, a single-order assay that combines exome, mitochondrial, and digital karyotype analysis, with 99% coverage of clinically relevant regions.
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.
The automated urinalysis system integrates chemistry and microscopy to help labs manage higher testing volumes and reduce manual reviews to under 3%, according to the company.